Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
25 09 2020
Historique:
accepted: 07 08 2020
revised: 15 07 2020
received: 07 11 2019
pubmed: 14 8 2020
medline: 11 11 2020
entrez: 14 8 2020
Statut: ppublish

Résumé

BRCA2 is a key breast cancer associated protein that is predicted to have interspersed regions of intrinsic disorder. Intrinsic disorder coupled with large size likely allows BRCA2 to sample a broad range of conformational space. We expect that the resulting dynamic arrangements of BRCA2 domains are a functionally important aspect of its role in homologous recombination DNA repair. To determine the architectural organization and the associated conformational landscape of BRCA2, we used scanning force microscopy based single molecule analyses to map the flexible regions of the protein and characterize which regions influence oligomerization. We show that the N- and the C-terminal regions are the main flexible regions. Both of these regions also influence BRCA2 oligomerization and interaction with RAD51. In the central Brc repeat region, Brc 1-4 and Brc 5-8 contribute synergistically to BRCA2 interaction with RAD51. We also analysed several single amino acid changes that are potentially clinically relevant and found one, the variant of F1524V, which disrupts key interactions and alters the conformational landscape of the protein. We describe the overall conformation spectrum of BRCA2, which suggests that dynamic structural transitions are key features of its biological function, maintaining genomic stability.

Identifiants

pubmed: 32785644
pii: 5891569
doi: 10.1093/nar/gkaa648
pmc: PMC7515699
doi:

Substances chimiques

BRCA2 Protein 0
BRCA2 protein, human 0
RAD51 protein, human EC 2.7.7.-
Rad51 Recombinase EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9649-9659

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Curr Biol. 2009 Jul 14;19(13):1075-85
pubmed: 19540122
J Chem Theory Comput. 2019 Apr 9;15(4):2672-2683
pubmed: 30865820
Nature. 2005 Mar 31;434(7033):598-604
pubmed: 15800615
Chem Rev. 2014 Jul 9;114(13):6715-32
pubmed: 24533462
DNA Repair (Amst). 2003 Sep 18;2(9):1015-28
pubmed: 12967658
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3515-20
pubmed: 26976601
Int J Biochem Cell Biol. 2011 Aug;43(8):1090-103
pubmed: 21501695
Science. 2012 Sep 21;337(6101):1460-1
pubmed: 22997313
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5213-8
pubmed: 24706910
Trends Biochem Sci. 2003 Feb;28(2):81-5
pubmed: 12575995
Biochemistry. 2002 May 28;41(21):6573-82
pubmed: 12022860
Nucleic Acids Res. 2010 Jan;38(1):82-96
pubmed: 19875419
Nucleic Acids Res. 2016 Jun 20;44(11):5256-70
pubmed: 27084934
Nat Chem Biol. 2009 Nov;5(11):789-96
pubmed: 19841628
Hum Mutat. 2003 Sep;22(3):259
pubmed: 12938098
Nat Struct Mol Biol. 2010 Oct;17(10):1263-5
pubmed: 20729858
Nature. 2002 Nov 21;420(6913):287-93
pubmed: 12442171
Biophys J. 2003 Jun;84(6):3924-30
pubmed: 12770898
Nat Struct Biol. 1998 Jul;5 Suppl:499-503
pubmed: 9665178
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10448-53
pubmed: 21670257
Nat Struct Mol Biol. 2010 Oct;17(10):1260-2
pubmed: 20729859
J Biol Chem. 1997 Dec 19;272(51):31941-4
pubmed: 9405383
Nat Struct Mol Biol. 2014 Nov;21(11):962-968
pubmed: 25282148
J Mol Biol. 2018 Aug 3;430(16):2309-2320
pubmed: 29634920
J Mol Biol. 2002 Oct 25;323(3):573-84
pubmed: 12381310
Cell Biochem Biophys. 2014 Nov;70(2):939-56
pubmed: 24817641
Hum Mutat. 2003 Feb;21(2):171
pubmed: 12552570
Nucleic Acids Res. 2020 Aug 20;48(14):7818-7833
pubmed: 32609828
Structure. 2007 May;15(5):599-609
pubmed: 17502105
J Am Chem Soc. 2001 Jun 20;123(24):5632-5
pubmed: 11403593
EMBO Rep. 2009 Sep;10(9):990-6
pubmed: 19609323
Nat Genet. 1996 May;13(1):22-3
pubmed: 8673099
Nucleic Acids Res. 2017 May 5;45(8):4507-4518
pubmed: 28168276
Science. 2002 Sep 13;297(5588):1837-48
pubmed: 12228710
Protein Sci. 2010 Aug;19(8):1555-64
pubmed: 20556825
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11385-90
pubmed: 23801766
FEBS J. 2005 Oct;272(20):5129-48
pubmed: 16218947
Nucleic Acids Res. 2007;35(17):5646-57
pubmed: 17709342
Nature. 2010 Oct 7;467(7316):678-83
pubmed: 20729832
Chem Rev. 2014 Jul 9;114(13):6589-631
pubmed: 24773235
Nat Struct Mol Biol. 2011 Jul 06;18(7):748-54
pubmed: 21731065
BMC Bioinformatics. 2015 Jan 28;16:27
pubmed: 25627825
Nat Struct Mol Biol. 2007 Jun;14(6):475-83
pubmed: 17515903

Auteurs

Arshdeep Sidhu (A)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Department of Radiation Oncology and Cancer Genomics Center, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Małgorzata Grosbart (M)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Humberto Sánchez (H)

Department of Bionanoscience, Kavli Institute of Nanoscience, Faculty of Applied Sciences, Delft University of Technology, 2628 CJ Delft, The Netherlands.

Bram Verhagen (B)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Nick L L van der Zon (NLL)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Dejan Ristić (D)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Sarah E van Rossum-Fikkert (SE)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Claire Wyman (C)

Department of Molecular Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Department of Radiation Oncology and Cancer Genomics Center, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH